NCT02929498 · Interventional trial
Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Myelodysplastic Syndrome, Myelodysplastic Syndromes
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory